TRP_1170x120_3-8-19

Sue Mahony

Lilly to acquire ARMO BioSciences

Lilly to acquire ARMO BioSciences

INDIANAPOLIS and REDWOOD CITY, Calif. — Eli Lilly and Company and ARMO BioSciences, Inc. announced a definitive agreement for Lilly to acquire ARMO for $50 per share, or approximately $1.6 billion, in an all-cash transaction. ARMO BioSciences is a late-stage immuno-oncology company that is developing a pipeline of novel, proprietary product candidates designed to activate